Hormonal
Liver-specific deletion of Protein-Tyrosine Phosphatase 1B (PTP1B) improves glucose homeostasis and lipid profiles in mice by enhancing hepatic insulin signaling and suppressing endoplasmic reticulum (ER) stress, independent of changes in body weight or adiposity.
This research suggests that improving insulin sensitivity specifically in the liver, potentially by inhibiting PTP1B, can fix metabolic issues like high blood sugar and bad cholesterol without needing to lose weight. While this is a genetic study in mice, it highlights the liver's critical role in metabolic health and suggests that future therapies might target liver-specific pathways to treat diabetes and metabolic syndrome.
Compared with normal littermates, liver-specific PTP1B(-/-) mice exhibit improved glucose homeostasis and lipid profiles, independent of changes in adiposity. Liver-specific PTP1B(-/-) mice have increased hepatic insulin signaling, decreased expression of gluconeogenic genes PEPCK and G-6-Pase, enhanced insulin-induced suppression of hepatic glucose production, and improved glucose tolerance.
Why this rating
High-quality controlled animal study with rigorous metabolic clamps and molecular analysis, but limited to murine models.
Source
Liver-Specific Deletion of Protein-Tyrosine Phosphatase 1B (PTP1B) Improves Metabolic Syndrome and Attenuates Diet-Induced Endoplasmic Reticulum Stress
Mirela Delibegović et al. · Diabetes · 2008
DOI 10.2337/db08-0913
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →